{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:34:07Z","timestamp":1761514447265,"version":"3.37.3"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA41854"],"award-info":[{"award-number":["MDA41854"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RoadMap Scholars Program","award":["5R25NS089463"],"award-info":[{"award-number":["5R25NS089463"]}]},{"name":"University of Alabama at Birmingham Center for Exercise Medicine","award":["T32HD071866"],"award-info":[{"award-number":["T32HD071866"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32-AI060573"],"award-info":[{"award-number":["T32-AI060573"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"an NIH National Institute of Allergy and Infectious Diseases","award":["1R21AI134657"],"award-info":[{"award-number":["1R21AI134657"]}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["2T32HD071866-06"],"award-info":[{"award-number":["2T32HD071866-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HHS"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R01HD095897","01AR064300"],"award-info":[{"award-number":["1R01HD095897","01AR064300"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institutes of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ymthe.2019.08.016","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T23:21:50Z","timestamp":1567552910000},"page":"189-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice"],"prefix":"10.1016","volume":"28","author":[{"given":"Rylie M.","family":"Hightower","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devin E.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Widrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis M.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna M.","family":"Kastenschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Armando","family":"Villalta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"van Groen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savanna","family":"Gornisiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosef","family":"Landesman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Tamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2019.08.016_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/323646a0","article-title":"Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene","volume":"323","author":"Monaco","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.08.016_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.08.016_bib3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/352536a0","article-title":"The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy","volume":"352","author":"Stedman","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.08.016_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-5728(95)00122-0","article-title":"Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls","volume":"63","author":"Lundberg","year":"1995","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.nmd.2008.02.002","article-title":"Mdx respiratory impairment following fibrosis of the diaphragm","volume":"18","author":"Ishizaki","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2019.08.016_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/mus.24998","article-title":"Increased collagen cross-linking is a signature of dystrophin-deficient muscle","volume":"54","author":"Smith","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2019.08.016_bib7","doi-asserted-by":"crossref","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2019.08.016_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ajmg.1320110314","article-title":"Collagen synthesis by Duchenne myogenic clones: pathogenic implications for the disease","volume":"11","author":"Ionasescu","year":"1982","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymthe.2019.08.016_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(82)90220-9","article-title":"Increased collagen synthesis by Duchenne myogenic clones","volume":"54","author":"Ionasescu","year":"1982","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ymthe.2019.08.016_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00441-009-0889-4","article-title":"Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-\u03b21 treatment","volume":"339","author":"Zanotti","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ymthe.2019.08.016_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/NEN.0b013e3181aa31c2","article-title":"Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation","volume":"68","author":"Desguerre","year":"2009","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2019.08.016_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.15844\/pedneurbriefs-30-3-4","article-title":"Guidelines for Corticosteroid use in Treatment of DMD","volume":"30","author":"Rao","year":"2016","journal-title":"Pediatr. Neurol. Briefs"},{"key":"10.1016\/j.ymthe.2019.08.016_bib14","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.0000000000002147","article-title":"Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy","volume":"85","author":"Peverelli","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2019.08.016_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.880170405","article-title":"Deflazacort in Duchenne dystrophy: study of long-term effect","volume":"17","author":"Angelini","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2019.08.016_bib16","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/WNL.41.12.1874","article-title":"Long-term benefit from prednisone therapy in Duchenne muscular dystrophy","volume":"41","author":"Fenichel","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2019.08.016_bib17","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T\u00a0cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.08.016_bib18","doi-asserted-by":"crossref","first-page":"258ra142","DOI":"10.1126\/scitranslmed.3009925","article-title":"Regulatory T\u00a0cells suppress muscle inflammation and injury in muscular dystrophy","volume":"6","author":"Villalta","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2019.08.016_bib19","doi-asserted-by":"crossref","first-page":"e90341","DOI":"10.1172\/jci.insight.90341","article-title":"Disease-modifying effects of orally bioavailable NF-\u03baB inhibitors in dystrophin-deficient muscle","volume":"1","author":"Hammers","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2019.08.016_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jcph.842","article-title":"A Novel NF-\u03baB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult Subjects","volume":"57","author":"Donovan","year":"2017","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ebiom.2015.02.014","article-title":"Functional and Morphological Improvement of Dystrophic Muscle by Interleukin 6 Receptor Blockade","volume":"2","author":"Pelosi","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2019.08.016_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nmd.2007.11.002","article-title":"Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment","volume":"18","author":"Radley","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2019.08.016_bib23","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ajpath.2011.02.024","article-title":"Inhibiting TGF-\u03b2 activity improves respiratory function in mdx mice","volume":"178","author":"Nelson","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib24","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1038\/s41467-018-05910-1","article-title":"NF-\u03baB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model","volume":"9","author":"Peterson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2019.08.016_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2044-5040-4-18","article-title":"NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy","volume":"4","author":"Kornegay","year":"2014","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2019.08.016_bib26","doi-asserted-by":"crossref","first-page":"e1010966","DOI":"10.1080\/21675511.2015.1010966","article-title":"The immune system in Duchenne muscular dystrophy: Friend or foe","volume":"3","author":"Villalta","year":"2015","journal-title":"Rare Dis."},{"key":"10.1016\/j.ymthe.2019.08.016_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrm1230","article-title":"The nuclear pore complex: nucleocytoplasmic transport and beyond","volume":"4","author":"Fahrenkrog","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrm.2016.147","article-title":"The nuclear pore complex: understanding its function through structural insight","volume":"18","author":"Beck","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nrm3461","article-title":"Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions","volume":"13","author":"Raices","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0092-8674(00)80370-0","article-title":"Exportin 1 (Crm1p) is an essential nuclear export factor","volume":"90","author":"Stade","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.08.016_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-5793(01)02487-5","article-title":"The rules and roles of nucleocytoplasmic shuttling proteins","volume":"498","author":"Gama-Carvalho","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2019.08.016_bib32","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2013-04-495374","article-title":"Preclinical and clinical efficacy of XPO1\/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias","volume":"122","author":"Walker","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2019.08.016_bib33","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1038\/leu.2013.172","article-title":"Genome-wide studies in multiple myeloma identify XPO1\/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276","volume":"27","author":"Schmidt","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2019.08.016_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature19771","article-title":"XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer","volume":"538","author":"Kim","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.08.016_bib35","doi-asserted-by":"crossref","first-page":"eaar7223","DOI":"10.1126\/scitranslmed.aar7223","article-title":"Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas","volume":"10","author":"Saenz-Ponce","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2019.08.016_bib36","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/hmg\/ddr049","article-title":"Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1","volume":"20","author":"Chan","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.016_bib37","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1523\/JNEUROSCI.0996-12.2012","article-title":"ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications","volume":"32","author":"Hart","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2019.08.016_bib38","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1212\/WNL.0000000000000778","article-title":"Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders","volume":"83","author":"Lattante","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2019.08.016_bib39","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1038\/s41598-018-22858-w","article-title":"TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"8","author":"Archbold","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.08.016_bib40","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1038\/s41598-018-25008-4","article-title":"Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization","volume":"8","author":"Pinarbasi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.08.016_bib41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.08.016_bib42","doi-asserted-by":"crossref","first-page":"e17951","DOI":"10.1371\/journal.pone.0017951","article-title":"PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2019.08.016_bib43","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.18632\/oncotarget.2174","article-title":"Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer","volume":"5","author":"Mendonca","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2019.08.016_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuron.2017.03.023","article-title":"Mutant Huntingtin Disrupts the Nuclear Pore Complex","volume":"94","author":"Grima","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2019.08.016_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.08.016_bib46","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1073\/pnas.1102116108","article-title":"Drug screening in a zebrafish model of Duchenne muscular dystrophy","volume":"108","author":"Kawahara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.016_bib47","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1083\/jcb.115.6.1685","article-title":"Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice","volume":"115","author":"Ohlendieck","year":"1991","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib48","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/hmg\/5.8.1149","article-title":"Differential expression of dystrophin isoforms in strains of mdx mice with different mutations","volume":"5","author":"Im","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.016_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.016_bib50","doi-asserted-by":"crossref","first-page":"38371","DOI":"10.1038\/srep38371","article-title":"Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA\/2 background","volume":"6","author":"Rodrigues","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.08.016_bib51","first-page":"e51785","article-title":"Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases","volume":"2014","author":"Tatem","year":"2014","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2019.08.016_bib52","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/mus.21211","article-title":"Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures","volume":"39","author":"Spurney","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2019.08.016_bib53","first-page":"e52434","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","volume":"2015","author":"Seibenhener","year":"2015","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2019.08.016_bib54","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.016_bib55","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.ajpath.2016.01.002","article-title":"Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy","volume":"186","author":"Kuraoka","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib56","doi-asserted-by":"crossref","first-page":"43697","DOI":"10.1038\/srep43697","article-title":"Identification of serum protein biomarkers for utrophin based DMD therapy","volume":"7","author":"Guiraud","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.08.016_bib57","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1096\/fj.03-1024com","article-title":"Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis","volume":"18","author":"Grounds","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2019.08.016_bib58","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1093\/hmg\/ddv323","article-title":"Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice","volume":"24","author":"Pelosi","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.016_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1083\/jcb.201510086","article-title":"Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype","volume":"213","author":"Capote","year":"2016","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13395-017-0140-z","article-title":"Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-\/utrophin-deficient mice","volume":"7","author":"Wada","year":"2017","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2019.08.016_bib61","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0002-9440(10)62333-4","article-title":"Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice","volume":"166","author":"Harcourt","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2019.08.016_bib62","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/hmg\/ddq523","article-title":"Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype","volume":"20","author":"Villalta","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.016_bib63","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1093\/hmg\/ddu113","article-title":"Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10","volume":"23","author":"Nitahara-Kasahara","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.016_bib64","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/hmg\/ddn376","article-title":"Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy","volume":"18","author":"Villalta","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.016_bib65","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2016-11-750174","article-title":"Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma","volume":"129","author":"Kuruvilla","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2019.08.016_bib66","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/cns.12501","article-title":"A Nuclear Attack on Traumatic Brain Injury: Sequestration of Cell Death in the Nucleus","volume":"22","author":"Tajiri","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ymthe.2019.08.016_bib67","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1091\/mbc.e12-01-0045","article-title":"NESdb: a database of NES-containing CRM1 cargoes","volume":"23","author":"Xu","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ymthe.2019.08.016_bib68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/hmg\/11.3.263","article-title":"A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice","volume":"11","author":"Porter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2019.08.016_bib69","series-title":"Duchenne Muscular Dystrophy: Methods and Protocols","first-page":"3","article-title":"An overview of recent therapeutics advances for Duchenne muscular dystrophy","author":"Mah","year":"2018"},{"key":"10.1016\/j.ymthe.2019.08.016_bib70","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.15252\/emmm.201403967","article-title":"Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2","volume":"6","author":"Mojumdar","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2019.08.016_bib71","doi-asserted-by":"crossref","first-page":"540370","DOI":"10.1155\/2013\/540370","article-title":"Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy","volume":"2013","author":"De Paepe","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.ymthe.2019.08.016_bib72","doi-asserted-by":"crossref","first-page":"E2585","DOI":"10.1073\/pnas.1800618115","article-title":"Treg cells limit IFN-\u03b3 production to control macrophage accrual and phenotype during skeletal muscle regeneration","volume":"115","author":"Panduro","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.08.016_bib73","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1212\/WNL.0000000000003217","article-title":"Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy","volume":"87","author":"Griggs","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2019.08.016_bib74","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0000000000001950","article-title":"Prednisone\/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study","volume":"85","author":"Bello","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2019.08.016_bib75","doi-asserted-by":"crossref","first-page":"e201800186","DOI":"10.26508\/lsa.201800186","article-title":"Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy","volume":"2","author":"Heier","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.ymthe.2019.08.016_bib76","first-page":"e4196","article-title":"Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction","volume":"2012","author":"Avdesh","year":"2012","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2019.08.016_bib77","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1242\/dev.00799","article-title":"Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo","volume":"130","author":"Bassett","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2019.08.016_bib78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pbb.2014.08.010","article-title":"Alternative method of oral administration by peanut butter pellet formulation results in target engagement of BACE1 and attenuation of gavage-induced stress responses in mice","volume":"126","author":"Gonzales","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ymthe.2019.08.016_bib79","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1038\/tp.2016.174","article-title":"Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A","volume":"6","author":"Alexander","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ymthe.2019.08.016_bib80","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.18632\/oncotarget.6495","article-title":"A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds","volume":"7","author":"Crochiere","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2019.08.016_bib81","first-page":"e58288","article-title":"The cutting and floating method for paraffin-embedded tissue for sectioning","volume":"2018","author":"Qin","year":"2018","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2019.08.016_bib82","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2019.08.016_bib83","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI73579","article-title":"MicroRNA-486-dependent modulation of DOCK3\/PTEN\/AKT signaling pathways improves muscular dystrophy-associated symptoms","volume":"124","author":"Alexander","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2019.08.016_bib84","series-title":"Duchenne Muscular Dystrophy: Methods and Protocols","first-page":"43","article-title":"Characterization of the Inflammatory Response in Dystrophic Muscle Using Flow Cytometry","author":"Kastenschmidt","year":"2018"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619303995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619303995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:28:51Z","timestamp":1736987331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001619303995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1525001619303995"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.016","relation":{},"ISSN":["1525-0016"],"issn-type":[{"type":"print","value":"1525-0016"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}